Skip to main content
Universal Ibogaine Inc. logo

Universal Ibogaine Inc. — Investor Relations & Filings

Ticker · IBO ISIN · CA91360F1099 LEI · 8755003NUNF8FDN4I397 TSXV Human health and social work activities
Open in API
Filings indexed 178 across all filing types
Latest filing 2026-01-03 Capital/Financing Update
Country CA Canada
Listing TSXV IBO

About Universal Ibogaine Inc.

https://universalibogaine.com/

Universal Ibogaine Inc. is a life sciences company focused on redefining addiction treatment by establishing a new standard of care centered on medicalized ibogaine. Ibogaine is a naturally-occurring psychedelic molecule derived from the iboga tree, recognized for its potent addiction-interrupting properties. The company is advancing its ibogaine-based drug detox protocol through planned clinical trials to demonstrate safety and efficacy. This protocol utilizes ibogaine, which metabolizes into noribogaine—a compound associated with the prolonged elimination of addictive cravings—integrated within a patient-centered, evidence-based holistic care model. UI is also developing a network of holistic recovery clinics to deliver these novel treatment modalities.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a 'Pricing Supplement' for a specific series of structured notes (BMO Callable Contingent Income Barrier Notes) issued by the Bank of Montreal. It details the terms, risks, and structure of a financial product offering. In the context of financial filings, a pricing supplement is a document that provides specific terms for a security offering under a base shelf prospectus. This falls under the category of capital and financing updates, as it relates to the issuance of debt securities.
2026-01-03 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a 'Default Status Report' issued by Universal Ibogaine Inc. in accordance with National Policy 12-203 regarding a Management Cease Trade Order (MCTO). It provides updates on the delay of annual financial filings and the company's restructuring process. Since this is a regulatory requirement for companies in default to provide periodic updates via news release, and it does not fit into specific categories like 10-K or ER, it is classified as a Regulatory Filing (RNS).
2025-12-19 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release from Universal Ibogaine Inc. announcing that it has applied for a Management Cease Trade Order (MCTO) due to its inability to file its annual financial statements and MD&A by the regulatory deadline. This is a regulatory disclosure regarding a filing delay and compliance status, which does not fit into specific categories like 10-K or IR, and is best classified as a general regulatory filing/announcement.
2025-11-25 English
News release - English.pdf
Capital/Financing Update Classification · 75% confidence The document is a corporate press release announcing a restructuring and that the Company is “pursuing various financing options” (including potential sale or lease of its property). It is not an earnings release, share issuance announcement, management or board change, or request for proxies. It specifically updates on financing activities and potential capital-structure changes, which matches the Capital/Financing Update category (CAP).
2025-10-28 English
News release - English.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is a press release announcing the detailed voting results from the company’s Annual Meeting of Shareholders, including counts and percentages for director elections, auditor appointment, and equity plan approvals. This precisely matches the definition of a Declaration of Voting Results & Voting Rights Announcement rather than a proxy circular or full annual report.
2025-09-15 English
Other.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Notice of Availability of Proxy Materials for an Annual General Meeting, providing shareholders with information on how to access and request the Management Information Circular, proxy materials, and voting instructions. This aligns precisely with the definition of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to request votes and provide meeting information. The document is not the meeting report itself but rather the solicitation of proxies and information statement.
2025-08-05 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.